Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland

Protein Expression and Purification

Volumn 37, Issue 1, 2004, Pages 102-108

  Roberto, Patrícia G ^a   Kashima, Simone ^a   Soares, Andreimar M ^a   Chioato, Lucimara ^b   Faça, Victor M ^b   Fuly, André L ^c   Astolfi Filho, Spartaco ^d   Pereira, José O ^d   França, Suzelei C ^a  

^a UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

Author keywords

Acidic phospholipases A2; Bothrops jararacussu snake; ESTs; Gene expression; Platelet aggregation inhibitor

Indexed keywords

ANTITHROMBOCYTIC AGENT; BOJU III PROTEIN, BOTHROPS JARARACUSSU; BOJU-III PROTEIN, BOTHROPS JARARACUSSU; ENZYME PRECURSOR; PHOSPHOLIPASE A; SNAKE VENOM; VIPER VENOM;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; ENZYMOLOGY; GENE LIBRARY; GENETICS; HISTOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PROTEIN CONFORMATION; SNAKE; THROMBOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PLATELETS; BOTHROPS; CLONING, MOLECULAR; CROTALID VENOMS; ENZYME PRECURSORS; GENE LIBRARY; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES A; PLATELET AGGREGATION INHIBITORS; PROTEIN CONFORMATION; VIPER VENOMS;

BOTHROPS; BOTHROPS JARARACUSSU; ESCHERICHIA COLI; SERPENTES; VECTORS;

EID: 3543113861     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.05.020     Document Type: Article

References (31)

1. 2. Annu. Rev. Pharmacol. Toxicol. 39:1999;175-189
2. 2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:2001;739-754
3. Arni R.K., Ward R.J. Crystallization of bothropstoxin II isolated from the venom of Bothrops jararacussu. Toxicon. 34:1996;827-841
4. 2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488:2000;1-19
5. 2 Enzymes: Structure, Function and Mechanism. 1997;1-28 Wiley, Chichester
6. Ownby C.L. Structure, function and biophysical aspects of the myotoxins from snake venoms. J. Toxicol. - Toxin Rev. 17:1998;213-238
7. Gutiérrez J.M. Understanding snake venoms: 50 years of research in Latin America. Rev. Biol. Trop. 50:2002;377-394
8. 2. Toxicon. 27:1989;613-635
9. 2 from snake venoms: effects on catalytic and pharmacological properties. Toxicon. 42:2003;855-868
10. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry. 29:1990;7742-7746
11. Cura J.E., Blanzaco D.P., Brisson C., Cura M.A., Cabrol R., Larrateguy L., Mendez C., Sechi J.C., Silveira J.S., Theiller E., de Roodt A.R., Vidal J.C. Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA2, NSC-624244) in patients with advanced cancer. Clin. Cancer Res. 8:2002;1033-1041
12. 2 from Bothrops asper snake venom. Eur. J. Biochem. 253:1998;452-461
13. 2 a new class of HIV inhibitors that block virus entry into host cells. J. Clin. Invest. 104:1999;611-618
14. 2 expressed from a synthetic gene in Escherichia coli. Biochim. Biophys. Acta. 1118:1992;107-115
15. 2 homologue, expressed as inclusion bodies in Escherichia coli. Protein Expr. Purif. 21:2001;134-140
16. 2 homologue, from Bothrops neuwiedi pauloensis venom. Arch. Biochem. Biophys. 378:2000;201-209
17. Lizano S., Lambeau G., Lazdunski M. Cloning and cDNA sequence analysis of Lys(49) and Asp(49) basic phospholipase A(2) myotoxin isoforms from Bothrops asper. Int. J. Biochem. Cell Biol. 33:2001;127-132
18. 2, with anticoagulant activity from Agkistrodon halys Pallas. J. Nat. Toxins. 10:2001;17-25
19. 2 myotoxin from Agkistrodon contortrix laticinctus snake venom. Arch. Biochem. Biophys. 326:1996;21-30
20. 2 from sea snake Lapemis hardwickii as a soluble protein in E. coli. Toxicon. 41:2003;713-721
21. 2: biological and membrane-disrupting activities in the absence of catalysis. Biochem. J. 362:2002;89-96
22. 2. Biochem. J. 366:2002;971-976
23. Kashima S., Soares A.M., Roberto P.G., Pereira J.O., Astolfi-Filho S., Cintra A.C.O., Fontes M.R.M., Giglio J.R., Franca S.C. cDNA sequence and molecular modeling of a nerve growth factor from Bothrops jararacussu venomous gland. Biochimie. 84:2002;675-680
24. 2 from Bothrops jararacussu venomous gland library. Protein J. 23:2004;273-285
25. 2 expressed from a synthetic gene in Escherichia coli: characterisation of N-terminal mutants. Biochim. Biophys. Acta. 1303:1996;92-102
26. Gutiérrez J.M., Avila C., Rojas E., Cerdas L. An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon. 26:1988;411-413
27. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb. Haemost. 78:1997;1372-1380
28. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 64:2002;723-732
29. 2 in Escherichia coli, a fully active enzyme generated by hydrolyzing with aminopeptidase. Biochem. Biophys. Res. Commun. 225:1996;990-996
30. 2. Biochimie. 86:2004;211-219
31. Rickles F.R., Edwards R.L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 62:1983;14-31